D.Sole provides smart insoles equipped with advanced sensors for early warning and monitoring of diabetic peripheral neuropathy complications. The system utilizes deep learning models to generate AI-based foot analysis reports accessible via a mobile app for patients and a clinician dashboard. This technology supports evidence-based treatment algorithms, aiming to improve patient compliance, enhance quality scores, and reduce the total cost of care.
Funding
Funding not disclosed
Founders
Product
Problem
Diabetic patients are at high risk for foot complications due to peripheral neuropathy, leading to delayed detection and intervention. This can result in serious adverse events, increased healthcare utilization, and a reduced quality of life for patients.
Solution
D.Sole offers smart insoles equipped with advanced pressure and gait sensors that continuously monitor foot health for individuals with diabetes. The integrated AI-powered mobile application analyzes sensor data to generate comprehensive foot health reports, identifying subtle changes indicative of developing complications. These reports are accessible to clinicians via a web dashboard, which also provides evidence-based treatment algorithms tailored to individual patient data. This proactive approach aims to improve patient compliance with monitoring protocols, enhance clinical quality scores, and ultimately reduce the total cost of care by preventing severe outcomes.
Target Audience
The primary target audience includes podiatrists, endocrinologists, and healthcare systems focused on value-based care for diabetic patient populations.
Features
- Smart insoles with embedded pressure and gait sensors for continuous foot health monitoring.
- AI-driven mobile application for real-time foot analysis and complication risk assessment.
- Generation of detailed foot health reports with actionable insights for clinicians.
- Web-based clinician dashboard featuring prescriptive treatment algorithms based on patient data.
- Proprietary machine learning models for identifying early indicators of diabetic foot complications.
- High patient compliance rate of 95% due to user-friendly design and reminder system.
- Seamless integration with footwear for daily wear.